SG11202112774XA - Compositions comprising cetylated fatty acids and use thereof in the treatment or arthritis and joint inflammatory conditions - Google Patents
Compositions comprising cetylated fatty acids and use thereof in the treatment or arthritis and joint inflammatory conditionsInfo
- Publication number
- SG11202112774XA SG11202112774XA SG11202112774XA SG11202112774XA SG11202112774XA SG 11202112774X A SG11202112774X A SG 11202112774XA SG 11202112774X A SG11202112774X A SG 11202112774XA SG 11202112774X A SG11202112774X A SG 11202112774XA SG 11202112774X A SG11202112774X A SG 11202112774XA
- Authority
- SG
- Singapore
- Prior art keywords
- arthritis
- compositions
- treatment
- fatty acids
- inflammatory conditions
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 230000004968 inflammatory condition Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Cardiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000007326A IT201900007326A1 (it) | 2019-05-27 | 2019-05-27 | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
PCT/IB2020/055028 WO2020240438A1 (en) | 2019-05-27 | 2020-05-27 | Compositions comprising cetylated fatty acids and use thereof in the treatment or arthritis and joint inflammatory conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202112774XA true SG11202112774XA (en) | 2021-12-30 |
Family
ID=67957311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202112774XA SG11202112774XA (en) | 2019-05-27 | 2020-05-27 | Compositions comprising cetylated fatty acids and use thereof in the treatment or arthritis and joint inflammatory conditions |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220211655A1 (he) |
EP (1) | EP3976184A1 (he) |
JP (1) | JP2022544894A (he) |
CN (1) | CN114126581A (he) |
BR (1) | BR112021022965A2 (he) |
CA (1) | CA3140989A1 (he) |
IL (1) | IL288269A (he) |
IT (1) | IT201900007326A1 (he) |
MA (1) | MA56040A (he) |
MX (1) | MX2021014371A (he) |
SG (1) | SG11202112774XA (he) |
WO (1) | WO2020240438A1 (he) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201900007329A1 (it) * | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia |
IT202100030170A1 (it) * | 2021-11-29 | 2023-05-29 | Pharmanutra S P A | Cerotto transdermico, e uso di detto cerotto in un metodo di trattamento di un disturbo, o disordine, o patologia, di un tendine |
WO2024184848A1 (en) * | 2023-03-07 | 2024-09-12 | Pharmanutra S.P.A. | Compositions comprising cetylated myristic acid, oleic acid, or a mixture thereofe, and vitamin d, and medical uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2519278C (en) | 2003-03-20 | 2012-06-05 | Imagenetix, Inc. | Esterified fatty acid composition |
US8404745B2 (en) * | 2011-03-16 | 2013-03-26 | Raj R. Barathur | Transdermal delivery of medicinal cetylated fatty esters using phonophoresis or iontophoresis |
US9861670B2 (en) * | 2013-03-13 | 2018-01-09 | Santalis Healthcare Corporation | Stabilized cream formulations comprising sandalwood oil |
ITUB20153130A1 (it) | 2015-08-14 | 2017-02-14 | Pharmanutra S P A | Acidi grassi cetilati, impianto per la loro preparazione e relativo uso |
GB2552952B (en) * | 2016-08-12 | 2020-03-04 | Norbrook Lab Ltd | Moxidectin topical liquid formulations |
-
2019
- 2019-05-27 IT IT102019000007326A patent/IT201900007326A1/it unknown
-
2020
- 2020-05-27 EP EP20742894.7A patent/EP3976184A1/en active Pending
- 2020-05-27 MX MX2021014371A patent/MX2021014371A/es unknown
- 2020-05-27 US US17/614,294 patent/US20220211655A1/en active Pending
- 2020-05-27 JP JP2021570463A patent/JP2022544894A/ja active Pending
- 2020-05-27 SG SG11202112774XA patent/SG11202112774XA/en unknown
- 2020-05-27 WO PCT/IB2020/055028 patent/WO2020240438A1/en active Application Filing
- 2020-05-27 BR BR112021022965A patent/BR112021022965A2/pt unknown
- 2020-05-27 CN CN202080039453.9A patent/CN114126581A/zh active Pending
- 2020-05-27 CA CA3140989A patent/CA3140989A1/en active Pending
- 2020-05-27 MA MA056040A patent/MA56040A/fr unknown
-
2021
- 2021-11-21 IL IL288269A patent/IL288269A/he unknown
Also Published As
Publication number | Publication date |
---|---|
CN114126581A (zh) | 2022-03-01 |
EP3976184A1 (en) | 2022-04-06 |
BR112021022965A2 (pt) | 2022-01-04 |
IT201900007326A1 (it) | 2020-11-27 |
WO2020240438A1 (en) | 2020-12-03 |
US20220211655A1 (en) | 2022-07-07 |
MX2021014371A (es) | 2022-02-21 |
JP2022544894A (ja) | 2022-10-24 |
MA56040A (fr) | 2022-04-06 |
CA3140989A1 (en) | 2020-12-03 |
IL288269A (he) | 2022-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288269A (he) | תכשירים המכילים חומצות שומן צטילטיות ושימוש בהם בטיפול בדלקת פרקים ובמצבים דלקתיים במפרקים | |
IL280479A (he) | אנטגוניסטים ל- tlr7/8 והשימוש בהם | |
ZA201702385B (en) | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states | |
ZA202007834B (en) | Compositions comprising amino acids for use in the prevention and treatment of liver diseases | |
IL263988B (he) | תכשירים שימושיים במניעה ו/או טיפול בדלקת עצם מפרק ,כאב ונזק בסחוס | |
IL271961A (he) | הרכבים המכילים תימוקווינון וחומצות שומן אומגה-3 | |
IL288882A (he) | תערובת תמציות צמחים לשימוש במניעה ו/או טיפול במחלות מעי דלקתיות כרוניות | |
IL250271B (he) | תערובת של חומצות שומן ופאלמיטוילאתנולאמיד לשימוש בטיפול בפתולוגיות דלקתיות ואלרגיות | |
IL277788B1 (he) | תכשיר דוחה חרקים המכיל חומצת שומן אחת או יותר דוחה חרקים בעלת בין 9 ל 21 אטומי פחמן | |
ZA202102991B (en) | Silicic acids for use in the treatment of periodontitis | |
PL3658133T3 (pl) | Kompozycje zawierające aminokwasy do zastosowania w leczeniu otyłości | |
PL3822335T3 (pl) | Kompozycje czyszczące i ich zastosowanie | |
IL288307A (he) | תכשירים לשימוש בטיפול במצבי חוסר באינסולין | |
GB201919268D0 (en) | Methods and compositions comprising carboxylic acids | |
EP3749332A4 (en) | COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ENDOMETRIOSIS AND PAIN | |
GB201901413D0 (en) | Compositions and their use | |
EP3768274C0 (en) | COMPOSITION CONTAINING A COMBINATION OF GLYCOCHOLIC ACID AND BUTYRIC ACID OR OLEIC ACID, FOR USE IN THE TREATMENT OF OSTEOPOROSIS | |
AU2018904835A0 (en) | Fatty acid compositions and the use thereof | |
AU2019904922A0 (en) | Fatty acid compositions and the use thereof | |
GB202101543D0 (en) | Vaping e-liquid composition and the use thereof | |
GB2585635B (en) | Compositions and methods for use in the preparation of hydrophobic surfaces | |
AU2021900069A0 (en) | Fatty acid compositions and the use thereof | |
IL261240B (he) | תכשירים שימושיים במניעה ו/או טיפול בדלקת ובכאב | |
AU2018900412A0 (en) | Compositions and their use in the treatment of endometriosis and pain | |
IL311782A (he) | טרנספוסאזים ושימושים שלהם |